IP Library › Assignment 023979/0193
Patent Assignment
Reel/Frame 023979/0193

Change of Name

Recorded: 2010-02-23 Pages: 6
Assignor
SCIELE PHARMA, INC.
Executed: 2010-01-11
Assignee
SHIONOGI PHARMA, INC.
FIVE CONCOURSE PARKWAY, SUITE 1800, ATLANTA, GEORGIA, 30328
Covered Properties (17)
Orally Disintegrating Tablet Comprising Glycopyrrolate for Treating Sialorrhea
Transdermal Delivery System Comprising Glycopyrrolate to Treat Sialorrhea
Derivatives of 1,2,3,4-Tetrahydro-9-Acrisinamine
Patent: 4,999,430 →
Application: 07/387,722 →
Compositions with Enhanced Penetration
Patent: 5,019,395 →
Application: 07/391,808 →
Controlled Release Tacrine Druge Delivery Systems and Methods for Preparing Same
Patent: 5,576,022 →
Application: 08/422,019 →
Tannate Compositions and Methods of Treatment
Patent: 6,509,492 →
Application: 09/952,711 →
Tannate Compositions and Methods of Treatment
Application: 10/056,805 →
Publication: US 2003/0060422
Tannate Compositions and Methods of Treatment
Patent: 6,790,980 →
Application: 10/263,276 →
Method for Increasing the Bioavailability of Glycopyrrolate
Patent: 7,091,236 →
Application: 10/644,530 →
Method for increasing the bioavailability of glycopyrrolate
Application: 11/334,020 →
Method for increasing the bioavailability of glycopyrrolate
Application: 11/586,837 →
Orally Disintegrating Tablet Comprising Glycopyrrolate for Treating Sialorrhea
Application: 11/738,452 →
Publication: US 2008/0260823
Transdermal Delivery System Comprising Glycopyrrolate to Treat Sialorrhea
Application: 12/144,285 →
Publication: US 2008/0317832
Method for Increasing the Bioavailability of Glycopyrrolate
Patent: 7,638,552 →
Application: 12/325,755 →
Method for Increasing the Bioavailability of Glycopyrrolate
Patent: 7,816,396 →
Application: 12/648,068 →
Tannate compositions and methods of treatment
Application: 60/316,548 →
Transdermal Delivery System Comprising Glycopyrrolate to Treat Sialorrhea
Application: 60/945,758 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Aug 30, 1989
From: KESTER, JEFFREY A.; MOOS, WALTER H.; THOMAS, ANTHONY J.
To: WARNER-LAMBERT COMPANY, A CORP. OF DE.
Reel/Frame 005124/0901 →
Assignment of Assignors Interest. Nov 6, 1989
From: MAHJOUR, MAJID; MAUSER, BERNADETTE; RASHIDBAIGI, ZAHRA; LINN, EDWARDS E.
To: WARNER-LAMBERT COMPANY, A CORP. OF DE
Reel/Frame 005204/0262 →
Assignment of Assignors Interest. Dec 18, 1989
From: KESTER, JEFFREY A.; MOOS, WALTER H.; THOMAS, ANTHONY J.
To: WARNER-LAMBERT COMPANY, A CORP. OF DE.
Reel/Frame 005197/0668 →
Assignment of Assignor's Interest Mar 29, 2001
From: WARNER-LAMBERT COMPANY
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 011658/0328 →
Assignment of Assignor's Interest Feb 8, 2002
From: VENKATARAMAN, BALAJI
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 012593/0537 →
Security Agreement Apr 1, 2002
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: BANKERS TRUST COMPANY
Reel/Frame 012762/0875 →
Please Note That U.S. Patent No. 5019395 Was Previously Erroneously Recorded as U.S Patent No. 5091395, on Reel 011658 Frame 0333 on March 29, 2001. Jun 14, 2002
From: WARNER-LAMBERT COMPANY
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 012991/0811 →
Assignment of Assignor's Interest Jun 14, 2002
From: VENKATARAMAN, BALAJI
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 012998/0306 →
Assignment of Assignor's Interest Jul 11, 2002
From: VENKATARAMAN, BALAJI
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 013080/0059 →
Release of Security Interest Feb 11, 2003
From: DEUTSCHE BANK TRUST COMPANY AMERICAS (F/K/A BANKERS TRUST COMPANY)
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 013791/0149 →
Security Interest Feb 24, 2003
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: LASALLE NATIONAL BANK ASSOCIATION
Reel/Frame 013774/0650 →
Assignment of Assignor's Interest Jul 17, 2003
From: VENKATARAMAN, BALAJI
To: FIRST HIRIZON PHARMACEUTICAL CORPORATION
Reel/Frame 014274/0138 →
Security Interest Jul 21, 2003
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: LASALLE NATIONAL BANK ASSOCIATION
Reel/Frame 014289/0670 →
Assignment of Assignor's Interest Jan 29, 2004
From: VENKATARAMAN, BALAJI
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 014293/0533 →
Assignment of Assignor's Interest Mar 24, 2004
From: ROBERTS, ALAN; VENKATARAMAN, BALAJI
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 014458/0484 →
Change of Name Jun 21, 2006
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: SCIELE PHARMA, INC.
Reel/Frame 017825/0622 →
Corrective Assignment to Correct the Application Number Previously Recorded on Reel 017825 Frame 0622. Assignor(S) Hereby Confirms the Change of Name. Jun 23, 2006
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: SCIELE PHARMA, INC.
Reel/Frame 017837/0004 →
Change of Name Jun 29, 2006
From: FIRST HORIZON PHARMACEUTICAL CORPORATION
To: SCIELE PHARMA, INC.
Reel/Frame 017858/0545 →
Security Agreement Sep 25, 2006
From: SCIELE PHARMA, INC.
To: GMAC COMMERCIAL FINANCE LLC
Reel/Frame 018303/0896 →
Release Sep 26, 2006
From: LASALLE BANK NATIONAL ASSOCIATION
To: FIRST HORIZON PHARMACEUTICAL CORPORATION
Reel/Frame 018338/0962 →
Assignment of Assignor's Interest Jul 9, 2008
From: DILLAHA, LARRY
To: SCIELE PHARMA, INC.
Reel/Frame 021214/0733 →
Release of Security Interest Apr 6, 2009
From: UBS AG, STAMFORD BRANCH
To: SCIELE PHARMA, INC.
Reel/Frame 022510/0181 →
Merger Apr 28, 2011
From: SHIONOGI PHARMA, INC.
To: SHIONOGI INC.
Reel/Frame 026195/0403 →
Assignment of Assignor's Interest Nov 7, 2012
From: SHIONOGI INC.
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 029253/0045 →